Multidimensional mechanisms of drug resistance in non-small cell lung cancer and novel strategies for overcoming it
World Journal of Clinical Oncology · 24.07.2026 · 17 (7)
DOI: 10.5306/wjco.121766 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 24.07.2026. Verfasst von Xiang-Yi Zhang und 8 weiteren Autor:innen. Die Arbeit nennt 147 Literaturangaben.
Abstract (Originalsprache)
Non-small cell lung cancer (NSCLC) has entered the era of precision medicine across all driver mutation subtypes and treatment settings; However, drug resistance mechanisms differ substantially across molecular subtypes and therapeutic contexts, and resistance remains a central challenge in routine clinical practice. The development of resistance is a complex, multidimensional, and spatiotemporally heterogeneous process involving the intrinsic genetic and epigenetic characteristics of tumor cells, the dynamic remodeling of the tumor microenvironment, and systemic host factors. This article summarizes the latest research advances in treatment resistance in NSCLC, delving deeply into the multidimensional nature of resistance across five dimensions: Molecular mechanisms and spatial heterogeneity, the temporal dynamics of resistance, heterogeneity of the tumor immune microenvironment, novel therapeutic strategies, and future directions for multi-omics integration. The review focuses on synergistic inhibition strategies targeting “undruggable” targets, monitoring the evolution of resistant clones via liquid biopsy, precision interventions based on immune microenvironment stratification, breakthroughs in novel therapeutic modalities such as antibody-drug conjugates, and how to utilize multi-omics data and advanced computational models to achieve personalized diagnosis and treatment. This article aims to provide a systematic theoretical framework and innovative solutions for understanding and overcoming treatment resistance in NSCLC.
Zitieren
APA
Zhang, X., Pan, X., Zhu, Y., Hu, M., Ma, S., Zheng, S., Wu, C., Xie, Y., & Xie, Y. (2026). Multidimensional mechanisms of drug resistance in non-small cell lung cancer and novel strategies for overcoming it. World Journal of Clinical Oncology, 17(7). https://doi.org/10.5306/wjco.121766
Vancouver
Zhang X, Pan X, Zhu Y, Hu M, Ma S, Zheng S, et al. Multidimensional mechanisms of drug resistance in non-small cell lung cancer and novel strategies for overcoming it. World Journal of Clinical Oncology. 2026;17(7). doi:10.5306/wjco.121766
BibTeX
@article{Zhang2026,
author = {Zhang, Xiang-Yi and Pan, Xin-Yu and Zhu, Yong and Hu, Min and Ma, Shuo and Zheng, Si-Yan and Wu, Ci-Hang and Xie, Yi-Luo and Xie, Yi-Chi},
title = {Multidimensional mechanisms of drug resistance in non-small cell lung cancer and novel strategies for overcoming it},
journal = {World Journal of Clinical Oncology},
year = {2026},
volume = {17},
number = {7},
doi = {10.5306/wjco.121766}
}
EUVIMED